JP2024539148A5 - - Google Patents
Info
- Publication number
- JP2024539148A5 JP2024539148A5 JP2024523646A JP2024523646A JP2024539148A5 JP 2024539148 A5 JP2024539148 A5 JP 2024539148A5 JP 2024523646 A JP2024523646 A JP 2024523646A JP 2024523646 A JP2024523646 A JP 2024523646A JP 2024539148 A5 JP2024539148 A5 JP 2024539148A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- score
- treatment
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163257876P | 2021-10-20 | 2021-10-20 | |
| US63/257,876 | 2021-10-20 | ||
| US202263300492P | 2022-01-18 | 2022-01-18 | |
| US63/300,492 | 2022-01-18 | ||
| EP22315048 | 2022-03-04 | ||
| EP22315048.3 | 2022-03-04 | ||
| PCT/US2022/078341 WO2023069976A1 (en) | 2021-10-20 | 2022-10-19 | Methods for treating prurigo nodularis by administering an il-4r antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539148A JP2024539148A (ja) | 2024-10-28 |
| JP2024539148A5 true JP2024539148A5 (https=) | 2025-10-27 |
Family
ID=84329583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523646A Pending JP2024539148A (ja) | 2021-10-20 | 2022-10-19 | Ｉｌ－４ｒアンタゴニストを投与することによって結節性痒疹を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230183362A1 (https=) |
| EP (1) | EP4419557A1 (https=) |
| JP (1) | JP2024539148A (https=) |
| KR (1) | KR20240099290A (https=) |
| CN (1) | CN119137149A (https=) |
| AU (1) | AU2022369296A1 (https=) |
| CA (1) | CA3235380A1 (https=) |
| IL (1) | IL312187A (https=) |
| MX (1) | MX2024004762A (https=) |
| WO (1) | WO2023069976A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9574004B2 (en) | 2012-08-21 | 2017-02-21 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an IL-4R antagonist |
| BR112022000740A2 (pt) | 2019-07-16 | 2022-07-05 | Sanofi Biotechnology | Métodos para tratamento ou prevenção de asma por administração de um antagonista de il-4r |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US8178098B2 (en) | 2001-04-03 | 2012-05-15 | National Jewish Health | Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies |
| JP5307708B2 (ja) | 2006-06-02 | 2013-10-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒトｉｌ−６受容体に対する高親和性抗体 |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| MY149079A (en) | 2006-10-02 | 2013-07-15 | Regeneron Pharma | High affinity human antibodies to human il-4 receptor |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| NZ609557A (en) | 2010-10-06 | 2014-12-24 | Regeneron Pharma | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| EP2823841A1 (en) | 2013-07-09 | 2015-01-14 | Sanofi-Aventis Deutschland GmbH | Autoinjector |
| TW201711716A (zh) | 2015-06-03 | 2017-04-01 | 賽諾菲阿凡提斯德意志有限公司 | 護罩鎖 |
| TW201709941A (zh) | 2015-06-03 | 2017-03-16 | 賽諾菲阿凡提斯德意志有限公司 | 聲響指示器（二） |
| TW201707738A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 注射器支架及自動注射器（二） |
| TW201707741A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 針頭護罩之抓握器、蓋子、自動注射器及製造抓握器之方法 |
| TW201711713A (zh) | 2015-06-03 | 2017-04-01 | 賽諾菲阿凡提斯德意志有限公司 | 藥物輸送裝置（五） |
| CN113372446A (zh) | 2016-06-08 | 2021-09-10 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| IL293487A (en) * | 2019-12-09 | 2022-08-01 | Sanofi Biotechnology | Methods for the treatment of digitally identified il-4/il-13-related disorders |
| CN113549151A (zh) | 2020-04-24 | 2021-10-26 | 苏州康乃德生物医药有限公司 | 与人IL-4Rα中特定表位结合的抗体及其应用 |
| US20230374144A1 (en) | 2020-09-10 | 2023-11-23 | Staidson (Beijing) Biopharmaceutical Co., Ltd. | Antibodies specifically recognizing interleukin-4 receptor alpha and uses thereof |
-
2022
- 2022-10-19 IL IL312187A patent/IL312187A/en unknown
- 2022-10-19 EP EP22800989.0A patent/EP4419557A1/en active Pending
- 2022-10-19 AU AU2022369296A patent/AU2022369296A1/en active Pending
- 2022-10-19 JP JP2024523646A patent/JP2024539148A/ja active Pending
- 2022-10-19 MX MX2024004762A patent/MX2024004762A/es unknown
- 2022-10-19 CN CN202280070927.5A patent/CN119137149A/zh active Pending
- 2022-10-19 KR KR1020247016221A patent/KR20240099290A/ko active Pending
- 2022-10-19 WO PCT/US2022/078341 patent/WO2023069976A1/en not_active Ceased
- 2022-10-19 US US17/969,033 patent/US20230183362A1/en active Pending
- 2022-10-19 CA CA3235380A patent/CA3235380A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Raborn et al. | Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study | |
| TWI643614B (zh) | 低頻率格拉替雷（ｇｌａｔｉｒａｍｅｒ）醋酸鹽之治療 | |
| CA2688766C (en) | Compositions and methods for treatment of multiple sclerosis | |
| JP2024539148A5 (https=) | ||
| Kim et al. | Guillain-Barre syndrome after two COVID-19 vaccinations: two case reports with follow-up electrodiagnostic study | |
| JP2023549455A5 (https=) | ||
| JP2024529434A5 (https=) | ||
| JP2024532263A5 (https=) | ||
| Thomson | Sudden death following an injection of penicillin | |
| JP2024542777A5 (https=) | ||
| CN106539815A (zh) | 环二核苷酸在防治多发性硬化症中的应用 | |
| CN114588164A (zh) | 瑞马唑仑在预防围术期低体温和寒战中的应用 | |
| JP2022526493A5 (https=) | ||
| RU2195314C1 (ru) | Способ лечения больных с атопическим дерматитом | |
| RU2345786C2 (ru) | Способ лечения непрерывно-прогредиентных дегенеративных и демиелинизирующих заболеваний | |
| Kuzminykh et al. | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | |
| JP7621411B2 (ja) | 慢性炎症性脱髄性多発神経炎の治療における使用のための免疫グロブリン製品 | |
| RU2153872C2 (ru) | Способ лечения дифтерии | |
| RU2489154C1 (ru) | Способ лечения вирусных гепатитов | |
| WO2026040961A1 (zh) | pUDK-HGF注射液的用途 | |
| US12486320B1 (en) | Compositions and methods for treatment of central nervous system (CNS) autoimmune associated diseases or disorders | |
| Dreschnack et al. | Case Report: Amyotrophic Lateral Sclerosis Treatment with Extracellular Vesicles derived from Mesenchymal Stromal Cells. Medical Research Archives,[online] 13 (9) | |
| RU2207135C2 (ru) | Способ лечения острого вирусного гепатита b | |
| Winter et al. | 0561 Solriamfetol Real World Experience Study: Safety, Efficacy, and Follow-Up for Patients with Obstructive Sleep Apnea in Germany | |
| CN106539816A (zh) | 环二核苷酸在防治多发性硬化症中的应用 |